Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism

Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of 10%. A stagnant high mortality rate over the last decades highlights the need for innovative therapeutic approaches. Pancreatic tumors pursue an altered metabolism in order to maintain energy generation und...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumstel, Simone, Schreiber, Tim, Goldstein, Lea, Stenzel, Jan, Lindner, Tobias, Joksch, Markus, Zhang, Xianbin, Wendt, Edgar Heinz Uwe, Schönrogge, Maria, Krause, Bernd, Vollmar, Brigitte, Zechner, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032382/
https://www.ncbi.nlm.nih.gov/pubmed/35452495
http://dx.doi.org/10.1371/journal.pone.0266601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032382/
https://www.ncbi.nlm.nih.gov/pubmed/35452495
http://dx.doi.org/10.1371/journal.pone.0266601

Ejemplares similares